Companies / Silence Therapeutics plc

Silence Therapeutics plc

Nasdaq: SLNCIK 1479615LONDON

Financials · FY2025

Revenue$559.0K
Net income$-88.61M
Total debt
Cash$72.05M
Diluted EPS$-0.63
Shares outstanding141.7M

Ownership

141.7M shares outstanding · as of Jul 31, 2026
13.8%Institutions
Ownership
Institutions13.85%19,627,253
Public float86.15%122,112,784

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Hellums Rhonda LynetteChief Financial Officer · Director
Lemus DavidDirector
Romano Steven J.EVP and Chief R&D Officer

Institutional holders 60

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Oct 27, 2025Griffiths Richard Ian
10% owner
BuyAmerican Depositary Shares+2K
+0.02%
11,825,861
8.34% of shares
low
Oct 27, 2025Griffiths Richard Ian
10% owner
SellAmerican Depositary Shares+2K
+0.02%
11,819,861
8.34% of shares
low
Aug 3, 2025Griffiths Richard Ian
10% owner
BuyAmerican Depositary Shares+20K
+0.17%
11,825,861
8.34% of shares
low
Aug 3, 2025Griffiths Richard Ian
10% owner
SellAmerican Depositary Shares+20K
+0.17%
11,805,861
8.33% of shares
low
Jan 2, 2026Hellums Rhonda Lynette
Executive
GrantEmployee Share Option (Right to Buy)+375K
375,000
0.26% of shares
low
Jan 2, 2026Lemus David
Director
GrantShare Option (Right to Buy)+90K
90,000
0.06% of shares
low
Jan 2, 2026Romano Steven J.
Executive
GrantEmployee Share Option (Right to Buy)+300K
300,000
0.21% of shares
low
Jan 2, 2026Ede-Golightly James
Director
GrantShare Option (Right to Buy)+90K
90,000
0.06% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lombard Odier Asset Management (USA) CorpPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SLNADREquity82686Q101BBG00WVTHPN2